Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing to take part and sign a consent form agreeing to participate.
- People who have been diagnosed with an advanced form of small cell lung cancer (a type of lung cancer that has spread widely), confirmed through a laboratory test of tissue or cell samples.
- People for whom a doctor has planned to use a medicine called Toripalimab as their first treatment.
- People who have medical records from their treatment period that can be reviewed and tracked.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Women who are pregnant or currently breastfeeding.
- People who are known to have had an allergic reaction to a type of cancer medicine called anti-PD-1 monoclonal antibody drugs, or to any of their ingredients.
- People who have any other condition that the trial doctor considers makes them unsuitable for the study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8618017312901
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Real-world Progression-Free Survival (rwPFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.